Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

436264

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plan to respond to the Accelerated Access Review: Interim Report, published in October 2015; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	19241
answer	answer is ministerial correction date of answer 15/12/2015 answer text <br /><p>The Interim Report of Sir Hugh Taylor’s Accelerated Access Review (AAR) is a deliberately high level document that indicates direction of travel; as such, government will be responding to the AAR’s conclusions when its final recommendations are published early in the spring of 2016.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:30:10 answering member 4020 label Biography information for George Freeman
tabling member	3960 label Biography information for Henry Smith

436265

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Leukaemia: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will ensure that the new Cancer Drugs Fund will increase patient access to medicines for acute myeloid leukaemia.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	19240
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>NHS England and the National Institute for Health and Care Excellence are currently consulting jointly on draft proposals on the future direction of the Cancer Drugs Fund.</p><br /><p>The consultation was published on 19 November 2015 and is open until 11 February 2016. It states that it is looking to put in place a solution that ensures patients have routine access to a greater range of cancer drugs, including earlier access to innovative drugs, while ensuring that cost-effectiveness is maintained. Further information is available at:</p><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:22:51 answering member 4020 label Biography information for George Freeman
tabling member	3960 label Biography information for Henry Smith

433989

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of multiple myeloma and the risks presented by late diagnosis of acute myeloid leukaemia.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18669
answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>Public Health England’s ‘Be Clear on Cancer’ campaigns do not currently include multiple myeloma.</p><br /><p>A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise.</p><br /><p>We appreciate that this means that there are a number of cancers, besides Myeloid Leukaemia, that are not covered by ‘Be Clear on Cancer’ specifically. Given this, Public Health England is looking at developing an approach to raise awareness of generic symptoms that can indicate a wider number of cancers and the need to visit the doctor promptly with these symptoms. This work is currently in development, with the help of a number of experts, including clinicians and charities.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 11:47:28 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

433998

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Myeloma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether an assessment has been made of the barriers preventing multiple myeloma patients accessing the most innovative treatments.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18708
answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>No specific assessment has been made of the barriers affecting access to the most innovative treatments for patients with multiple myeloma.</p><br /><p>It is essential that a robust process is in place to ensure that patients get rapid access to the most innovative drugs that represent value for money to the National Health Service. The Cancer Drugs Fund has helped over 84,000 people to access the life-extending drugs they need, and NHS England and the National Institute for Health and Care Excellence are currently consulting on the future shape of the Fund to put it on a more sustainable footing.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 12:18:24 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

434007

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Myeloma: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that the treatment of patients with multiple myeloma is not affected by the (a) delisting of treatments from the Cancer Drugs Fund and (b) ongoing consultation on that Fund's future.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18734
answer	answer is ministerial correction date of answer 10/12/2015 answer text <p>NHS England has advised that a draft treatment pathway for patients with multiple myeloma, which takes into account the potential impact of treatments removed from the Cancer Drugs Fund (CDF), is currently being finalised. It is likely to be published early in 2016.</p><br /><p>The Government remains committed to the Fund. NHS England and the National Institute for Health and Care Excellence are currently consulting on draft proposals on the future direction of the CDF. The consultation is open until 11 February 2016 and further information is available at:</p><br /><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 10/12/2015 14:17:08 answering member 4020 label Biography information for George Freeman
tabling member	3960 label Biography information for Henry Smith

434008

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure the outcome of the consultation on the future of the Cancer Drugs Fund is co-ordinated with and complements the recommendations of the Accelerated Access Review to ensure improved patient access to innovative treatments.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18766
answer	answer is ministerial correction date of answer 10/12/2015 answer text <p>NHS England and the National Institute for Health and Care Excellence are currently consulting on draft proposals on the future direction of the Cancer Drugs Fund (CDF). The consultation is open until 11 February 2016 and further information is available at:</p><br /><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p><br /><p>The Accelerated Access Review independently chaired by Sir Hugh Taylor, is working with key stakeholders on a range of options for accelerating patient access to innovative products, as set out in the interim report. This includes consideration of the impact of managed access schemes such as proposed in the CDF consultation.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 10/12/2015 14:04:50 answering member 4020 label Biography information for George Freeman
tabling member	3960 label Biography information for Henry Smith

428358

registered interest
date	16/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to improve the assessment of medicines for rarer cancers with small patient populations.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	16497
answer	answer is ministerial correction date of answer 23/11/2015 answer text <p>NHS England has advised that it intends to jointly consult with the National Institute for Health and Care Excellence on proposals for a new Cancer Drugs Fund operating model. This will include the future arrangements for the evaluation of cancer drugs, including drugs for rarer cancers with small patient populations. Members of the public and any interested parties will have the opportunity to consider and comment on these proposals.</p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 16188 question first answered 23/11/2015 10:58:14 answering member 4020 label Biography information for George Freeman
tabling member	3960 label Biography information for Henry Smith

427717

registered interest
date	10/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Leukaemia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what comparative assessment his Department has made of the (a) cost and (b) effectiveness of stem cell transplants and tyrosine kinase inhibitor therapies as treatments for chronic myeloid leukaemia.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	15807
answer	answer is ministerial correction date of answer 19/11/2015 answer text <p>As the treatments referred to are mutually exclusive, NHS England has no plans to carry out such an assessment. Patients will only be offered a transplant when they are unsuitable for tyrosine kinase inhibitor (TKI) treatment, or if this treatment has failed.</p><br /><p>Both imatinib (usually considered the first line option) and nilotinib are recommended by the National Institute for Health and Care Excellence as cost effective treatments for chronic myeloid leukaemia (CML). Dasatinib, bosutinib and ponatinib are only available for certain patients through the Cancer Drugs Fund.</p><p>In 2013, NHS England published a policy for the routine commissioning of allogeneic stem cell transplant for CML. This can be found at:</p><br /><p><a href="http://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/01/b04-haematp-stem-cll-transplt.pdf" target="_blank">www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/01/b04-haematp-stem-cll-transplt.pdf</a></p><p>This policy allows for transplant in patients whose CML is refractory to TKI treatment, or where the patient is TKI intolerant. It takes into account expert advice from the British Society for Blood and Marrow Transplantation.</p><p>Based on the clinical pathway of care, no specific assessment of cost or effectiveness comparing blood and marrow transplantation with TKI has been undertaken.</p><br /><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 19/11/2015 17:31:59 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

426559

registered interest
date	05/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to improve children and young people's mental health services.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	15092
answer	answer is ministerial correction date of answer 12/11/2015 answer text <p>Children and young people’s mental health is a priority area for this Government. We are committed to delivering the vision set out in <em>Future in mind</em> through the launch of a major system-wide transformation programme working alongside our partners in Government and arm’s length bodies. This will improve access and make services more widely available across the country.</p><br /><p>To support this transformation, an additional£1.4 billion funding has been made available over the course of this Parliament for spending on children and young people’s mental health, of which we are spending £173 million this year, including £30 million on eating disorders. This will be used to improve community-based services so that young people are helped earlier and are less likely to need to go into hospital. It will also enable the expansion and extension of the Children and Young People’s Improving Access to Psychological Therapies programme so that a wider range of those who need it are able to access high quality and evidence-based interventions wherever they may live. All clinical commissioning groups have been asked to work with their partners to develop Local Transformation Plans to transform their local offer to improve children and young people’s mental health and wellbeing.</p><br /><p>A national programme of work will support local areas, including the extension and expansion of the use of evidence- based interventions, tackling stigma, improving data and information to inform greater transparency and accountability and developing a specialist and stronger workforce.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 12/11/2015 10:03:31 answering member 1201 label Biography information for Alistair Burt
tabling member	3960 label Biography information for Henry Smith

419533

registered interest
date	17/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Urinary System: Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many catheter associated urinary tract infection related deaths there were in the last three years.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	10618
answer	answer is ministerial correction date of answer 12/10/2015 answer text <p>This information is not available in the format requested.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/10/2015 10:57:21 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith